Leptin is a growth factor in cancer

Journal of Surgical Research

Volumn 116, Issue 2, 2004, Pages 337-349

  Somasundar, Ponnandai ^a   McFadden, David W ^a   Hileman, Stanley M ^a   Vona Davis, Linda ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; LEPTIN;

ADIPOCYTE; ADIPOSE TISSUE; ANGIOGENESIS; ANOREXIA; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CARCINOGENESIS; CELL DIFFERENTIATION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; GYNECOLOGIC CANCER; HUMAN; LEUKEMIA; METASTASIS; MUTATION; NEOPLASM; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

EID: 0842328722     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.09.004     Document Type: Review

References (175)

1. Schoeller D.A., Cella L.K., Sinha M.K., Caro J.F. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J. Clin. Invest. 100:1997;1882.
2. Sinha M.K., Ohannesian J.P., Heiman M.L., Kriauciunas A., Stephens T.W., Magosin S., Marco C., Caro J.F. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 97:1996;1344.
3. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250.
4. Flier J.S. Clinical review 94 What's in a name? In search of leptin's physiologic role . J Clin. Endocrinol. Metab. 83:1998;1407.
5. Boden G., Chen X., Mozzoli M., Ryan I. Effect of fasting on serum leptin in normal human subjects. J. Clin. Endocrinol. Metab. 81:1996;3419.
6. Frederich R.C., Lollmann B., Hamann A., Napolitano-Rosen A., Kahn B.B., Lowell B.B., Flier J.S. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin. Invest. 96:1995;1658.
7. der Merwe M.T., Panz V.R., Crowther N.J., Schlaphoff G.P., Gray I.P., Froguel P., Joffe B.I., Lonnroth P.N. Free fatty acids and insulin levels - Relationship to leptin levels and body composition in various patient groups from South Africa. J. Obes. Relat. Metab. Disord. 23:1999;909.
8. Thomas T., Burguera B., Melton L.J. III, Atkinson E.J., O'Fallon W.M., Riggs B.L., Khosla S. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism. 49:2000;1278.
9. Blum W.F., Englaro P., Attanasio A.M., Kiess W., Rascher W. Human and clinical perspectives on leptin. Proc. Nutr. Soc. 57:1998;477.
10. Kolaczynski J.W., Considine R.V., Ohannesian J., Marco C., Opentanova I., Nyce M.R., Myint M., Caro J.F. Responses of leptin to short-term fasting and refeeding in humans A link with ketogenesis but not ketones themselves . Diabetes. 45:1996;1511.
11. Kolaczynski J.W., Ohannesian J.P., Considine R.V., Marco C.C., Caro J.F. Response of leptin to short-term and prolonged overfeeding in humans. J. Clin. Endocrinol. Metab. 81:1996;4162.
12. Hamilton B.S., Paglia D., Kwan A.Y., Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat. Med. 1:1995;953.
13. Korbonits M., Trainer P.J., Little J.A., Edwards R., Kopelman P.G., Besser G.M., Svec F., Grossman A.B. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin. Endocrinol. (Oxf.). 46:1997;751.
14. Licinio J., Mantzoros C., Negrao A.B., Cizza G., Wong M.L., Bongiorno P.B., Chrousos G.P., Karp B., Allen C., Flier J.S., Gold P.W. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat. Med. 3:1997;575.
15. Havel P.J., Kasim-Karakas S., Dubuc G.R., Mueller W., Phinney S.D. Gender differences in plasma leptin concentrations. Nat. Med. 2:1996;949.
16. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., Leibel R.L. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab. 81:1996;3424.
17. Hube F., Lietz U., Igel M., Jensen P.B., Tornqvist H., Joost H.G., Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm. Metab. Res. 28:1996;690.
18. Montague C.T., Prins J.B., Sanders L., Digby J.E., O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression Implications for the control of regional fat distribution . Diabetes. 46:1997;342.
19. Saad M.F., Riad-Gabriel M.G., Khan A., Sharma A., Michael R., Jinagouda S.D., Boyadjian R., Steil G.M. Diurnal and ultradian rhythmicity of plasma leptin Effects of gender and adiposity . J. Clin. Endocrinol. Metab. 83:1998;453.
20. Casabiell X., Pineiro V., Peino R., Lage M., Camina J., Gallego R., Vallejo L.G., Dieguez C., Casanueva F.F. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro Dexamethasone and estradiol stimulate leptin release in women, but not in men . J. Clin. Endocrinol. Metab. 83:1998;2149.
21. Castracane V.D., Kraemer R.R., Franken M.A., Kraemer G.R., Gimpel T. Serum leptin concentration in women Effect of age, obesity, and estrogen administration . Fertil. Steril. 70:1998;472.
22. Blum W.F. Leptin The voice of the adipose tissue . Horm. Res. 48:(Suppl. 4):1997;2.
23. Elbers J.M., Asscheman H., Seidell J.C., Frolich M., Meinders A.E., Gooren L.J. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J. Clin. Endocrinol. Metab. 82:1997;3267.
24. Jockenhovel F., Blum W.F., Vogel E., Englaro P., Muller-Wieland D., Reinwein D., Rascher W., Krone W. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J. Clin. Endocrinol. Metab. 82:1997;2510.
25. Hardie L.J., Guilhot N., Trayhurn P. Regulation of leptin production in cultured mature white adipocytes. Horm. Metab. Res. 28:1996;685.
26. Leroy P., Dessolin S., Villageois P., Moon B.C., Friedman J.M., Ailhaud G., Dani C. Expression of ob gene in adipose cells. Regulation by insulin. J. Biol. Chem. 271:1996;2365.
27. Cusin I., Sainsbury A., Doyle P., Rohner-Jeanrenaud F., Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes. 44:1995;1467.
28. Saladin R., De Vos P., Guerre-Millo M., Leturque A., Girard J., Staels B., Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:1995;527.
29. Segal K.R., Landt M., Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 45:1996;988.
30. MacDougald O.A., Hwang C.S., Fan H., Lane M.D. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA. 92:1995;9034.
31. Mueller W.M., Gregoire F.M., Stanhope K.L., Mobbs C.V., Mizuno T.M., Warden C.H., Stern J.S., Havel P.J. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology. 139:1998;551.
32. Dagogo-Jack S., Selke G., Melson A.K., Newcomer J.W. Robust leptin secretory responses to dexamethasone in obese subjects. J. Clin. Endocrinol. Metab. 82:1997;3230.
33. De Vos P., Saladin R., Auwerx J., Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270:1995;15958.
34. Ahima R.S., Prabakaran D., Flier J.S. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J. Clin. Invest. 101:1998;1020.
35. Heiman M.L., Ahima R.S., Craft L.S., Schoner B., Stephens T.W., Flier J.S. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology. 138:1997;3859.
36. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 396:1998;670.
37. Trayhurn P., Duncan J.S., Hoggard N., Rayner D.V. Regulation of leptin production a dominant role for the sympathetic nervous system? Proc. Nutr. Soc. 57:1998;413.
38. Rayner D.V., Simon E., Duncan J.S., Trayhurn P. Hyperleptinaemia in mice induced by administration of the tyrosine hydroxylase inhibitor alpha-methyl-p-tyrosine. FEBS Lett. 429:1998;395.
39. Mantzoros C.S., Qu D., Frederich R.C., Susulic V.S., Lowell B.B., Maratos-Flier E., Flier J.S. Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 45:1996;909.
40. Trayhurn P., Duncan J.S., Rayner D.V., Hardie L.J. Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the beta 3-adrenoceptor agonists BRL 35135A and ZD2079. Biochem. Biophys. Res. Commun. 228:1996;605.
41. Finck B.N., Johnson R.W. Tumor necrosis factor (TNF)-alpha induces leptin production through the p55 TNF receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R537.
42. Finck B.N., Kelley K.W., Dantzer R., Johnson R.W. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology. 139:1998;2278.
43. Zhang H.H., Kumar S., Barnett A.H., Eggo M.C. Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol. Cell Endocrinol. 159:2000;79.
44. Gottschling-Zeller H., Birgel M., Scriba D., Blum W.F., Hauner H. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture Effect of tumor necrosis factor-alpha and transforming growth factor-beta1 . Eur. J. Endocrinol. 141:1999;436.
45. Medina E.A., Stanhope K.L., Mizuno T.M., Mobbs C.V., Gregoire F., Hubbard N.E., Erickson K.L., Havel P.J. Effects of tumor necrosis factor alpha on leptin secretion and gene expression Relationship to changes of glucose metabolism in isolated rat adipocytes . Int. J. Obes. Relat. Metab. Disord. 23:1999;896.
46. Yamaguchi M., Murakami T., Tomimatsu T., Nishio Y., Mitsuda N., Kanzaki T., Kurachi H., Shima K., Aono T., Murata Y. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Biochem. Biophys. Res. Commun. 244:1998;30.
47. Kirchgessner T.G., Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J. Clin. Invest. 100:1997;2777.
48. Sattar N., Greer I.A., Pirwani I., Gibson J., Wallace A.M. Leptin levels in pregnancy Marker for fat accumulation and mobilization? Acta Obstet. Gynecol. Scand. 77:1998;278.
49. Henson M.C., Castracane V.D. Leptin in pregnancy. Biol. Reprod. 63:2000;1219.
50. Henson M.C., Castracane V.D., O'Neil J.S., Gimpel T., Swan K.F., Green A.E., Shi W. Serum leptin concentrations and expression of leptin transcripts in placental trophoblast with advancing baboon pregnancy. J Clin. Endocrinol. Metab. 84:1999;2543.
51. Clapp J.F. III, Kiess W. Cord blood leptin reflects fetal fat mass. J Soc. Gynecol. Invest. 5:1998;300.
52. Kiess W., Siebler T., Englaro P., Kratzsch J., Deutscher J., Meyer K., Gallaher B., Blum W.F. Leptin as a metabolic regulator during fetal and neonatal life and in childhood and adolescence. J. Pediatr. Endocrinol. Metab. 11:1998;483.
53. Mantzoros C.S., Moschos S.J. Leptin In search of role(s) in human physiology and pathophysiology . Clin. Endocrinol. (Oxf.). 49:1998;551.
54. Bouloumie A., Drexler H.C., Lafontan M., Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83:1998;1059.
55. Laud K., Gourdou I., Pessemesse L., Peyrat J.P., Djiane J. Identification of leptin receptors in human breast cancer Functional activity in the T47-D breast cancer cell line . Mol. Cell Endocrinol. 188:2002;219.
56. Ahima R.S., Bjorbaek C., Osei S., Flier J.S. Regulation of neuronal and glial proteins by leptin Implications for brain development . Endocrinology. 140:1999;2755.
57. Smith J.T., Waddell B.J. Developmental changes in plasma leptin and hypothalamic leptin receptor expression in the rat Peripubertal changes and the emergence of sex differences . J. Endocrinol. 176:2003;313.
58. Suter K.J., Pohl C.R., Wilson M.E. Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys Potential signals for the initiation of puberty . J. Clin. Endocrinol. Metab. 85:2000;808.
59. Mantzoros C.S., Flier J.S., Rogol A.D. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J. Clin. Endocrinol. Metab. 82:1997;1066.
60. Urbanski H.F., Pau K.Y. A biphasic developmental pattern of circulating leptin in the male rhesus macaque (Macaca mulatta). Endocrinology. 139:1998;2284.
61. Plant T.M., Durrant A.R. Circulating leptin does not appear to provide a signal for triggering the initiation of puberty in the male rhesus monkey (Macaca mulatta). Endocrinology. 138:1997;4505.
62. Garcia-Mayor R.V., Andrade M.A., Rios M., Lage M., Dieguez C., Casanueva F.F. Serum leptin levels in normal children Relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage . J. Clin. Endocrinol. Metab. 82:1997;2849.
63. Chehab F.F. The reproductive side of leptin. Nat. Med. 3:1997;952.
64. Ahima R.S., Dushay J., Flier S.N., Prabakaran D., Flier J.S. Leptin accelerates the onset of puberty in normal female mice. J. Clin. Invest. 99:1997;391.
65. Cheung C.C., Thornton J.E., Kuijper J.L., Weigle D.S., Clifton D.K., Steiner R.A. Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology. 138:1997;855.
66. Gruaz N.M., Lalaoui M., Pierroz D.D., Englaro P., Sizonenko P.C., Blum W.F., Aubert M.L. Chronic administration of leptin into the lateral ventricle induces sexual maturation in severely food-restricted female rats. J. Neuroendocrinol. 10:1998;627.
67. Hileman S.M., Tornoe J., Flier J.S., Bjorbaek C. Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby canine kidney cells. Endocrinology. 141:2000;1955.
68. Tollefsbol T.O., Cohen H.J. Role of protein molecular and metabolic aberrations in aging, in the physiologic decline of the aged, and in age-associated diseases. J. Am. Geriatr. Soc. 34:1986;282.
69. Rinn W.E. Mental decline in normal aging A review . J. Geriatr. Psychiatry Neurol. 1:1988;144.
70. Fraze E., Chiou Y.A., Chen Y.D., Reaven G.M. Age-related changes in postprandial plasma glucose, insulin, and free fatty acid concentrations in nondiabetic individuals. J. Am. Geriatr. Soc. 35:1987;224.
71. Ahren B., Mansson S., Gingerich R.L., Havel P.J. Regulation of plasma leptin in mice Influence of age, high-fat diet, and fasting . Am. J. Physiol. 273:1997;R113.
72. Li H., Matheny M., Nicolson M., Tumer N., Scarpace P.J. Leptin gene expression increases with age independent of increasing adiposity in rats. Diabetes. 46:1997;2035.
73. Sanchez-Rodriguez M., Garcia-Sanchez A., Retana-Ugalde R., Mendoza-Nunez V.M. Serum leptin levels and blood pressure in the overweight elderly. Arch. Med. Res. 31:2000;425.
74. Banerji M.A., Faridi N., Atluri R., Chaiken R.L., Lebovitz H.E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J. Clin. Endocrinol. Metab. 84:1999;137.
75. Wang Z.W., Pan W.T., Lee Y., Kakuma T., Zhou Y.T., Unger R.H. The role of leptin resistance in the lipid abnormalities of aging. FASEB J. 15:2001;108.
76. Gabriely I., Ma X.H., Yang X.M., Rossetti L., Barzilai N. Leptin resistance during aging is independent of fat mass. Diabetes. 51:2002;1016.
77. Kohn E.C., Liotta L.A. Invasion and metastasis New approaches to an old problem . Oncology (Huntingt.). 7:1993;47.
78. Rose D.P., Gilhooly E.M., Nixon D.W. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin. (Review) Int. J. Oncol. 21:2002;1285.
79. Singh J., Hamid R., Reddy B.S. Dietary fat and colon cancer Modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis . Cancer Res. 57:1997;3465.
80. Rose D.P. Effects of dietary fatty acids on breast and prostate cancers Evidence from in vitro experiments and animal studies . Am. J. Clin. Nutr. 66:1997;1513S.
81. Rose D.P., Connolly J.M. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 83:1999;217.
82. Rose D.P., Connolly J.M. Dietary fat and breast cancer metastasis by human tumor xenografts. Breast Cancer Res. Treat. 46:1997;225.
83. Takahashi Y., Ide T. Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br. J. Nutr. 84:2000;175.
84. Raclot T., Groscolas R., Langin D., Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J. Lipid Res. 38:1997;1963.
85. Hun C.S., Hasegawa K., Kawabata T., Kato M., Shimokawa T., Kagawa Y. Increased uncoupling protein2 mRNA in white adipose tissue, and decrease in leptin, visceral fat, blood glucose, and cholesterol in KK-Ay mice fed with eicosapentaenoic and docosahexaenoic acids in addition to linolenic acid. Biochem. Biophys. Res. Commun. 259:1999;85.
86. Wang H., Storlien L.H., Huang X.F. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am. J. Physiol. Endocrinol. Metab. 282:2002;E1352.
87. Park H.Y., Kwon H.M., Lim H.J., Hong B.K., Lee J.Y., Park B.E., Jang Y., Cho S.Y., Kim H.S. Potential role of leptin in angiogenesis Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro . Exp. Mol. Med. 33:2001;95.
88. Oda A., Taniguchi T., Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J. Med. Sci. 47:2001;141.
89. Hardwick J.C., Van Den Brink G.R., Offerhaus G.J., Van Deventer S.J., Peppelenbosch M.P. Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 121:2001;79.
90. Liu Z., Uesaka T., Watanabe H., Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int. J. Oncol. 19:2001;1009.
91. Dieudonne M.N., Machinal-Quelin F., Serazin-Leroy V., Leneveu M.C., Pecquery R., Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 293:2002;622.
92. Liekens S., De Clercq E., Neyts J. Angiogenesis Regulators and clinical applications . Biochem. Pharmacol. 61:2001;253.
93. Smith S.K. Regulation of angiogenesis in the endometrium. Trends Endocrinol. Metab. 12:2001;147.
94. Spranger J., Pfeiffer A.F. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp. Clin. Endocrinol. Diabetes. 109:(Suppl. 2):2001;S438.
95. Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:1990;4.
96. Rose D.P., Connolly J.M. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr. Cancer. 37:2000;119.
97. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist. 5:(Suppl. 1):2000;37.
98. Toi M., Inada K., Suzuki H., Tominaga T. Tumor angiogenesis in breast cancer Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression . Breast Cancer Res. Treat. 36:1995;193.
99. Heimann R., Ferguson D., Powers C., Recant W.M., Weichselbaum R.R., Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst. 88:1996;1764.
100. Engels K., Fox S.B., Harris A.L. Angiogenesis as a biologic and prognostic indicator in human breast carcinoma. EXS. 79:1997;113.
101. Linderholm B.K., Lindahl T., Holmberg L., Klaar S., Lennerstrand J., Henriksson R., Bergh J. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res. 61:2001;2256.
102. Hursting S.D., Perkins S.N., Phang J.M., Barrett J.C. Diet and cancer prevention studies in p53-deficient mice. J. Nutr. 131:2001;3092S.
103. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., Madge L.A., Schechner J.S., Schwabb M.B., Polverini P.J., Flores-Riveros J.R. Biological action of leptin as an angiogenic factor. Science. 281:1998;1683.
104. Kume K., Satomura K., Nishisho S., Kitaoka E., Yamanouchi K., Tobiume S., Nagayama M. Potential role of leptin in endochondral ossification. J. Histochem. Cytochem. 50:2002;159.
105. Artwohl M., Roden M., Holzenbein T., Freudenthaler A., Waldhausl W., Baumgartner-Parzer S.M. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int. J. Obes. Relat. Metab. Disord. 26:2002;577.
106. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. USA. 98:2001;6390.
107. Ribatti D., Nico B., Belloni A.S., Vacca A., Roncali L., Nussdorfer G.G. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int. J. Mol. Med. 8:2001;265.
108. Vona-Davis L., Tighe G., Vedula G., Somasundar P., McFadden D.W. Leptin decreases VEGF production in vitro. American Gastroenterology Association at Digestive Diseases Week. 2003;. May 17-22, 2003, Orlando, FL; Abstract T997.
109. Stetler-Stevenson W.G. The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg. Oncol. Clin. N. Am. 10:2001;383.
110. Jones J.L., Glynn P., Walker R.A. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J. Pathol. 189:1999;161.
111. Hanemaaijer R., Verheijen J.H., Maguire T.M., Visser H., Toet K., McDermott E., O'Higgins N., Duffy M.J. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer. 86:2000;204.
112. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., Wymann M.P., Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 14:2000;2329.
113. Brunetti L., Orlando G., Michelotto B., Ragazzoni E., Vacca M. Leptin stimulates prostaglandin E2 and F2alpha, but not nitric oxide production in neonatal rat hypothalamus. Eur. J. Pharmacol. 369:1999;299.
114. Fain J.N., Leffler C.W., Bahouth S.W. Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture. J. Lipid Res. 41:2000;1689.
115. Fain J.N., Leffler C.W., Cowan G.S. Jr, Buffington C., Pouncey L., Bahouth S.W. Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans. Metabolism. 50:2001;921.
116. Somasundar P., Vona-Davis L., Riggs D., Jackson B., McFadden D.W. COX-2 inhibition reverses leptin-stimulated breaset cancer growth in vitro. American Gastroenterology Association at Digestive Diseases Week. 2003;. May 17-22, Orlando, FL; Abstract W1005.
117. Takekoshi K., Ishii K., Nanmoku T., Shibuya S., Kawakami Y., Isobe K., Nakai T. Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology. 142:2001;4861.
118. Wang A., Nomura M., Patan S., Ware J.A. Inhibition of protein kinase Calpha prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo. Circ. Res. 90:2002;609.
119. Lagiou P., Signorello L.B., Trichopoulos D., Tzonou A., Trichopoulou A., Mantzoros C.S. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int. J. Cancer. 76:1998;25.
120. Chang S., Hursting S.D., Contois J.H., Strom S.S., Yamamura Y., Babaian R.J., Troncoso P., Scardino P.S., Wheeler T.M., Amos C.I., Spitz M.R. Leptin and prostate cancer. Prostate. 46:2001;62.
121. Stattin P., Soderberg S., Hallmans G., Bylund A., Kaaks R., Stenman U.H., Bergh A., Olsson T. Leptin is associated with increased prostate cancer risk A nested case-referent study . J. Clin. Endocrinol. Metab. 86:2001;1341.
122. Hsing A.W., Chua S. Jr, Gao Y.T., Gentzschein E., Chang L., Deng J., Stanczyk F.Z. Prostate cancer risk and serum levels of insulin and leptin A population-based study . J. Natl. Cancer Inst. 93:2001;783.
123. Somasundar P., Yu A., Vona-Davis L., McFadden D.W. Differential responses of leptin on cancer in vitro. J. Surg. Res. 113:2002;50.
124. Vona-Davis L., Skinner H., Jackson B., Somasundar P., McFadden D.W. Leptin activates MAPK signaling in human breast and prostate cancer. 37th Annual Meeting of the Association for Academic Surgery. 2003;. Sacramento, CA, Abstract P89.
125. Vona-Davis L., Vedula G., McFadden D.W., VanGilder R., Hileman S.M. Identification of leptin receptor isoforms in human prostate. 37th Annual Meeting of the Association for Academic Surgery. 2003;. Sacramento, CA, Abstract P95.
126. Chilliard Y., Bonnet M., Delavaud C., Faulconnier Y., Leroux C., Djiane J., Bocquier F. Leptin in ruminants. Gene expression in adipose tissue and mammary gland, and regulation of plasma concentration. Domest. Anim. Endocrinol. 21:2001;271.
127. O'brien S.N., Welter B.H., Price T.M. Presence of leptin in breast cell lines and breast tumors. Biochem. Biophys. Res. Commun. 259:1999;695.
128. Magoffin D.A., Weitsman S.R., Aagarwal S.K., Jakimiuk A.J. Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. Ginekol. Pol. 70:1999;1.
129. Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M.E., Koo J., Madarnas Y., Hartwick W., Hoffman B., Hood N. Fasting insulin and outcome in early-stage breast cancer Results of a prospective cohort study . J. Clin. Oncol. 20:2002;42.
130. Askari H., Liu J., Dagogo-Jack S. Hormonal regulation of human leptin in vivo Effects of hydrocortisone and insulin . Int. J. Obes. Relat. Metab. Disord. 24:2000;1254.
131. Miller W.R., Mullen P., Sourdaine P., Watson C., Dixon J.M., Telford J. Regulation of aromatase activity within the breast. J. Steroid Biochem. Mol. Biol. 61:1997;193.
132. Marttunen M.B., Andersson S., Hietanen P., Karonen S.L., Koistinen H.A., Koivisto V.A., Tiitinen A., Ylikorkala O. Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients. Maturitas. 35:2000;175.
133. Baum M., Budzar A.U., Cuzick J., Forbes J., Houghton J.H., Klijn J.G., Sahmoud T. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer First results of the ATAC randomised trial . Lancet. 359:2002;2131.
134. Hu X., Juneja S.C., Maihle N.J., Cleary M.P. Leptin - A growth factor in normal and malignant breast cells and for normal mammary gland development. J. Natl. Cancer Inst. 94:(22):2002;1704.
135. Petridou E., Belechri M., Dessypris N., Koukoulomatis P., Diakomanolis E., Spanos E., Trichopoulos D. Leptin and body mass index in relation to endometrial cancer risk. Ann. Nutr. Metab. 46:2002;147.
136. Lebrecht A., Ludwig E., Huber A., Klein M., Schneeberger C., Tempfer C., Koelbl H., Hefler L. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol. Oncol. 85:2002;32.
137. Baile C.A., Della-Fera M.A., Martin R.J. Regulation of metabolism and body fat mass by leptin. Annu. Rev. Nutr. 20:2000;105.
138. Bahceci M., Tuzcu A., Akkus M., Yaldiz M., Ozbay A. The effect of high-fat diet on the development of obesity and serum leptin level in rats. Eat. Weight Disord. 4:1999;128.
139. Lin X., Chavez M.R., Bruch R.C., Kilroy G.E., Simmons L.A., Lin L., Braymer H.D., Bray G.A., York D.A. The effects of a high fat diet on leptin mRNA, serum leptin and the response to leptin are not altered in a rat strain susceptible to high fat diet-induced obesity. J. Nutr. 128:1998;1606.
140. Alberts D.S., Einspahr J., Rees-McGee S., Ramanujam P., Buller M.K., Clark L., Ritenbaugh C., Atwood J., Pethigal P., Earnest D. Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. J. Natl. Cancer Inst. 82:1990;1280.
141. Agus M.S., Swain J.F., Larson C.L., Eckert E.A., Ludwig D.S. Dietary composition and physiologic adaptations to energy restriction. Am. J. Clin. Nutr. 71:2000;901.
142. Liew C., Schut H.A., Chin S.F., Pariza M.W., Dashwood R.H. Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4, 5-f]quinoline-induced colon carcinogenesis in the F344 rat A study of inhibitory mechanisms . Carcinogenesis. 16:1995;3037.
143. Rahman S.M., Wang Y., Yotsumoto H., Cha J., Han S., Inoue S., Yanagita T. Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta-oxidation of fatty acid in OLETF rats. Nutrition. 17:2001;385.
144. Chu N.F., Stampfer M.J., Spiegelman D., Rifai N., Hotamisligil G.S., Rimm E.B. Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men. Int. J. Obes. Relat. Metab. Disord. 25:2001;106.
145. Wang Y., Kuropatwinski K.K., White D.W., Hawley T.S., Hawley R.G., Tartaglia L.A., Baumann H. Leptin receptor action in hepatic cells. J. Biol. Chem. 272:1997;16216.
146. Arpaci F., Yilmaz M.I., Ozet A., Ayta H., Ozturk B., Komurcu S., Ozata M. Low serum leptin level in colon cancer patients without significant weight loss. Tumori. 88:2002;147.
147. Tessitore L., Vyzyo B. A novel marker for breast cancer progression. Second Balkan Congress of Oncology. 1998;163-167. Izmir-Turkey.
148. Wallace A.M., Sattar N., McMillan D.C. Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. Clin. Cancer Res. 4:1998;2977.
149. Morton N.M., Emilsson V., Liu Y.L., Cawthorne M.A. Leptin action in intestinal cells. J. Biol. Chem. 273:1998;26194.
150. Azuma T., Suto H., Ito Y., Ohtani M., Dojo M., Kuriyama M., Kato T. Gastric leptin and Helicobacter pylori infection. Gut. 49:2001;324.
151. Cioffi J.A., Shafer A.W., Zupancic T.J., Smith-Gbur J., Mikhail A., Platika D., Snodgrass H.R. Novel B219/OB receptor isoforms Possible role of leptin in hematopoiesis and reproduction . Nat. Med. 2:1996;585.
152. Bennett B.D., Solar G.P., Yuan J.Q., Mathias J., Thomas G.R., Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol. 6:1996;1170.
153. Nakao T., Hino M., Yamane T., Nishizawa Y., Morii H., Tatsumi N. Expression of the leptin receptor in human leukaemic blast cells. Br. J. Haematol. 102:1998;740.
154. Konopleva M., Mikhail A., Estrov Z., Zhao S., Harris D., Sanchez-Williams G., Kornblau S.M., Dong J., Kliche K.O., Jiang S., Snodgrass H.R., Estey E.H., Andreeff M. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes Proliferative and anti-apoptotic activities . Blood. 93:1999;1668.
155. Inui A. Cancer anorexia-cachexia syndrome Are neuropeptides the key? Cancer Res. 59:1999;4493.
156. Carlson G.L., Saeed M., Little R.A., Irving M.H. Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am. J. Physiol. 276:1999;E658.
157. Arnalich F., Lopez J., Codoceo R., Jim N.M., Madero R., Montiel C. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J. Infect. Dis. 180:1999;908.
158. Papathanassoglou E.D., Moynihan J.A., Ackerman M.H., Mantzoros C.S. Serum leptin levels are higher but are not independently associated with severity or mortality in the multiple organ dysfunction/systemic inflammatory response syndrome A matched case control and a longitudinal study . Clin. Endocrinol. (Oxf.). 54:2001;225.
159. Moses A.G., Dowidar N., Holloway B., Waddell I., Fearon K.C., Ross J.A. Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients. Br. J. Surg. 88:2001;588.
160. Takabatake N., Nakamura H., Abe S., Hino T., Saito H., Yuki H., Kato S., Tomoike H. Circulating leptin in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159:1999;1215.
161. Schols A.M., Creutzberg E.C., Buurman W.A., Campfield L.A., Saris W.H., Wouters E.F. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160:1999;1220.
162. Murdoch D.R., Rooney E., Dargie H.J., Shapiro D., Morton J.J., McMurray J.J. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart. 82:1999;352.
163. Filippatos G.S., Tsilias K., Venetsanou K., Karambinos E., Manolatos D., Kranidis A., Antonellis J., Kardaras F., Anthopoulos L., Baltopoulos G. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system. Int. J. Cardiol. 76:2000;117.
164. Yarasheski K.E., Zachwieja J.J., Horgan M.M., Powderly W.G., Santiago J.V., Landt M. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism. 46:1997;303.
165. Ballinger A., Kelly P., Hallyburton E., Besser R., Farthing M. Plasma leptin in chronic inflammatory bowel disease and HIV Implications for the pathogenesis of anorexia and weight loss . Clin. Sci. (Lond.). 94:1998;479.
166. Aleman M.R., Santolaria F., Batista N., de L.V., Gonzalez-Reimers E., Milena A., Llanos M., Gomez-Sirvent J.L. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine. 19:2002;21.
167. Simons J.P., Schols A.M., Campfield L.A., Wouters E.F., Saris W.H. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin. Sci. (Lond.). 93:1997;273.
168. Brown D.R., Berkowitz D.E., Breslow M.J. Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer. J. Clin. Endocrinol. Metab. 86:2001;162.
169. Mantovani G., Maccio A., Mura L., Massa E., Mudu M.C., Mulas C., Lusso M.R., Madeddu C., Dessi A. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J. Mol. Med. 78:2000;554.
170. Oliveira A.M., Nascimento A.G., Lloyd R.V. Leptin and leptin receptor mRNA are widely expressed in tumors of adipocytic differentiation. Mod. Pathol. 14:2001;549.
171. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348:2003;1625.
172. Mantzoros C.S., Bolhke K., Moschos S., Cramer D.W. Leptin in relation to carcinoma in situ of the breast A study of pre-menopausal cases and controls . Int. J. Cancer. 80:1999;523.
173. Ozet A., Arpaci F., Yilmaz M.I., Ayta H., Ozturk B., Komurcu S., Yavuz A.A., Tezcan Y., Acikel C. Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn. J. Clin. Oncol. 31:2001;424.
174. Okumura M., Yamamoto M., Sakuma H., Kojima T., Maruyama T., Jamali M., Cooper D.R., Yasuda K. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells Reciprocal involvement of PKC-alpha and PPAR expression . Biochim. Biophys. Acta. 1592:2002;107.
175. Arpaci F., Yilmaz M.I., Ozet A., Ayta H., Ozturk B., Komurcu S., Ozata M. Low serum leptin level in colon cancer patients without significant weight loss. Tumori. 88:2002;147.